Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

28th Psychiatric Pharmacotherapy Update 2016 • Pharmacist (for CPE credit)


The University of Texas College of Pharmacy welcomes you to the 2016 Psychiatric Pharmacotherapy Update CE event, in Austin, Texas on October 27-28. The Psychiatric Pharmacotherapy Update traditionally provides 15 hours of CEU's on current treads in mental illness treatment for pharmacists, physicians, psychiatrists, psychologists, advance practice nurses, counselors, and social workers.

Hotel Reservations:  See Location website here for more information

Date: Oct 27, 2016 07:45 AM - Oct 28, 2016 04:00 PM

Fee

$425.00

CE Hours

15.00

CE Units

1.500

Registration closes on Oct 28, 2016 09:00 AM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
 

Requirements for CE Credit

ACPE Logo

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This two-day activity is approved for 1.5 CEUs (15 contact hours) of continuing education credit.  In order to receive 15 contact hours of CE credit, the participant must attend/participate in all sessions of the program, return their completed Record of Attendance Form at the conclusion of the program, and return to this website to complete the online evaluation.

 
MUST COMPLETE CPE EVALUATIONS BY DECEMBER 26, 2016, OR FORFEIT CPE CREDIT
As of May 1, 2014, ACPE has placed a strict limit of 60 days to complete the CPE requirements for credit for all pharmacy continuing education programs.  
Pharmacists who fail to complete the requirements for credit for this program will forfit CPE credit for this activity.   Per rule set by ACPE, The University of Texas at Austin College of Pharmacy will not be able to process credit after the 60 day deadline, and will not be able to route credits to the NABP eProfiles. 
This includes error caused by incorrect NABP#'s and/or Date of Birth on you profile. Please ensure your information is correct and up-to-date prior to completing the evaluations.  It is up to the conference attendee to ensure their credits have been received. 


 

 

Registration closes on Oct 28, 2016 at 09:00 AM

Registration Closed  

Objectives

  • Discuss current trends in the treatment of Alzheimer’s disease and other dementia disorders
  • Discuss impact of substance abuse in relation to dementia disorders

Speaker(s)/Author(s)

Jason E. Schillerstrom, MD picture

Jason E. Schillerstrom, MD
Associate Professor, Department of Psychiatry, University of Texas Health Science Center San Anto

Activity Number

0067-0000-16-041-L01-P
Date: 10/27/16
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the pathophysiology and the challenges associate with diagnosis of epileptic seizures.
  • Identify new treatment options available for the management of epilepsy.

Speaker(s)/Author(s)

Collin Hovinga, Pharm.D., M.S., FCCP picture

Collin Hovinga, Pharm.D., M.S., FCCP
Director of Research Clinical Associate Professor, The University of Texas at Austin College of Pharm


Disclosure : Dr. Hovinga has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

Activity Number

0067-0000-16-042-L01-P
Date: 10/27/16
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Define the problem of agitation in emergency psychiatry.
  • Identify the unique legal and ethical issues involved in the psychiatric management of agitation.
  • Discuss the pharmacological options for treatment of acute agitation in an emergency department.

Speaker(s)/Author(s)

Keith S. Garcia, MD, PhD picture

Keith S. Garcia, MD, PhD
Associate Professor in Psychiatry, University of Texas at Austin Dell Medical School


Disclosure : Dr. Garcia has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

Activity Number

0067-0000-16-043-L01-P
Date: 10/27/16
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe current and advanced process of detection of prescription drug abuse with patients.
  • Discuss current trends in intervention and treatment with patients who have been detected in abusing prescription drug abuse.
  • Discuss ethical dilemmas practitioners face when dealing with a patient who is abusing prescription drugs.

Speaker(s)/Author(s)

Kimberly Arlinghaus, MD picture

Kimberly Arlinghaus, MD
Medical Director of Psychiatry and Behavioral Health, Lone Star Circle of Care


Disclosure : Dr. Arlinghaus has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

Activity Number

0067-0000-16-044-L01-P
Date: 10/27/16
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Discuss naloxone pharmacology, produce availability, and device delivery.
  • Discuss the epidemiology of opiate overdose and naloxone therapy outcomes.
  • Discuss ethical and treatment issues with naloxone therapy, availability and outreach.

Speaker(s)/Author(s)

Nile J. Barnes. Pharm.D. picture

Nile J. Barnes. Pharm.D.
Alumni Centennial Endowed Fellow in Pharmacy Clinical Assistant Professor of Health Outcomes & Pharmacy Practice, The University of Texas at Austin College of Pharm


Disclosure : Dr. Barnes is a Team Leader for the UT Austin program Operation Naloxine.org – which solicits and receives donations from Kaleo and Adapt for the Texas Overdose Naloxine Initiative (TONI).

Activity Number

0067-0000-16-045-L04-P
Date: 10/27/16
Time: 01:00 PM - 02:00 PM

CE Hours

1.25
Registration Closed  

Registration Closed  

Presentation Slides
Click on the link below to download / open the presentation slides in PDF format.

Objectives

  • Identify the differential diagnosis of attention problems from childhood to adulthood
  • Discuss how to use both pharmacological and psychosocial interventions in adult ADHD.

Speaker(s)/Author(s)

Ali Abbas Asghar-Ali, M.D. picture

Ali Abbas Asghar-Ali, M.D.
Associate Professor, Baylor College of Medicine & DeBakey VA Medical Ce


Brief Bio : Associate Director for Education, South Central MIRECC Director of Geriatric Psychiatry Fellowship Associate Professor, Baylor College of Medicine Geriatric Psychiatrist, Michael E. DeBakey VA Medical Center
Disclosure : Dr. Ali Abbas Asghar-Ali has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

Activity Number

0067-0000-16-046-L01-P
Date: 10/27/16
Time: 02:15 PM - 03:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs recently marketed as well as drugs approaching the market.
  • Review pharmacology, adverse effects, drug interactions, therapeutic uses, and dosing of selected psychiatric drugs that have been released in the past five years.

Speaker(s)/Author(s)

Stephen R. Saklad picture

Stephen R. Saklad, Pharm.D., BCPP
Clinical Associate Professor, UT Austin College of Pharmacy / Director, Psychiatric Pharmacy Program, UT Health Science Center San Antonio , UT Austin College of Pharmacy


Disclosure : Financial Disclosure: consultant or advisory role with Eli Lilly and Ortho McNeil Janssen; on the speaker’s bureau for Janssen, Merck, and Novartis; investigator Ortho McNeil Janssen

Activity Number

0067-0000-16-047-L04-P
Date: 10/27/16
Time: 03:30 PM - 05:00 PM

CE Hours

1.50
Registration Closed  

Registration closes on Oct 28, 2016 at 09:00 AM

Registration Closed  

Objectives

  • Recognize current trends of prescription medication abuse with emphasis on non-scheduled prescription medications.
  • Explain rationales and methodologies of prescription medication abuse.
  • Describe best practice methods for working with patients and prescribers to detect suspected substance use disorders and deter prescription drug diversion.

Speaker(s)/Author(s)

Michael O’Neil, Pharm.D. picture

Michael O’Neil, Pharm.D.
Professor and Chair Department of Pharmacy Practice Drug Diversion, Substance Abuse, and Pain Management, South College School of Pharmacy


Disclosure : Dr. O’Neil has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

Activity Number

0067-0000-16-048-L01-P
Date: 10/28/16
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Discuss the scale of the issues caused by metabolic disorders.
  • Describe the implication of metabolic disorders as they relate to the morbidity and mortality of patients.
  • Describe what actions can be taken to mitigate these metabolic risks.

Speaker(s)/Author(s)

R. Lowell McRoberts, M.D.  picture

R. Lowell McRoberts, M.D.
Assistant Professor of Psychiatry Department of Psychiatry, The University of Texas Dell Medical School


Disclosure : Dr. McRoberts has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

Activity Number

0067-0000-16-049-L01-P
Date: 10/28/16
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Discuss new treatment strategies in the treatment of bipolar disorder.
  • Identify changes in treatment trends over the past five years.
  • Discuss benefits of an inter professional approach in the treatment of bipolar disorders.

Speaker(s)/Author(s)

Stephen Strakowski, M.D.  picture

Stephen Strakowski, M.D.
Chair of Psychiatry, The University of Texas Dell Medical School


Disclosure : Dr. Starkowski has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose: Consultant: Chair of DSMB’s for Sunovion, human resources consultant for Procter & Gamble

Activity Number

0067-0000-16-050-L01-P
Date: 10/28/16
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Discuss trends in use of synthetic cannabis.
  • Discuss trends in use of synthetic drug such as bath salts in the general population.
  • Discuss benefits of an inter professional approach in the treatment of bipolar disorders.

Speaker(s)/Author(s)

Carlos Tirado, M.D., M.P.H., F.A.B.A.M picture

Carlos Tirado, M.D., M.P.H., F.A.B.A.M
Founder and Owner, ABRI Integrated Health


Disclosure : Dr. Tirado has the following relevant financial relationships, potential or perceived, with commercial or conflicts of interest to disclose: Speakers Bureau: Indivior & Alkermes Consultant: US WorldMeds as a Medical Monitor

Activity Number

0067-0000-16-051-L04-P
Date: 10/28/16
Time: 11:15 AM - 12:15 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Discuss the connection between microbiome and brain function.
  • Review research connection microbiome-gut brain axis and specific mental health disorders of depression, anxiety and autism.
  • Discuss the interactions between the microbiome-gut brain axis and common psychiatric medications.

Speaker(s)/Author(s)

Ruth Ann Luna, Ph.D., MB(ASCP)CM picture

Ruth Ann Luna, Ph.D., MB(ASCP)CM
Assistant Professor, Baylor College of Medicine , Texas Children’s Microbiome Center, Texas Children


Disclosure : Dr. Luna has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

Activity Number

0067-0000-16-052-L01-P
Date: 10/28/16
Time: 12:30 PM - 01:45 PM

CE Hours

1.25
Registration Closed  

Registration Closed  

Objectives

  • Diagnose borderline personality disorder (BPD) according to the new DSM-5 Alternative Model for Personal Disorders.
  • Discuss the longitudinal course of BPD.
  • Discuss the latest evidence-based recommendations for the treatment of patients with BPD.

Speaker(s)/Author(s)

John M. Oldham, M.D., M.S. picture

John M. Oldham, M.D., M.S.
Professor Barbara & Corbin Robertson, Jr. Endowed Chair for Personality Disorders Menninger Department of Psychiatry and Behavioral Sciences, Baylor School of Medicine


Disclosure : Dr. Oldham has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

Activity Number

0067-0000-16-053-L01-P
Date: 10/28/16
Time: 02:00 PM - 03:00 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the new atypical antipsychotics available in the US.
  • Describe new evidence in treating first episode schizophrenia.
  • Describe new evidence supporting augmentation strategies in treatment-resistant schizophrenia.

Speaker(s)/Author(s)

Troy Moore PharmD, MS Pharm, BCPP picture

Troy Moore PharmD, MS Pharm, BCPP
Clinical Pharmacy Specialist – Psychiatry Director, ASHP-Accredited PGY-2 Psychiatric Pharmacy Residency Program Co-Director, Interprofessional Advanced Fellowship in Addiction Treatment, South Texas Veterans Health Care System


Disclosure : Financial Disclosure: no relevant financial relationships to disclose

Activity Number

0067-0000-16-054-L01-P
Date: 10/28/16
Time: 03:00 PM - 03:50 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Date: 10/28/16
Time: 09:00 AM - 09:15 AM
Registration Closed